- Q2 2024 Nykode Therapeutics ASA Earnings Call Transcript5 days agokr18.69Earnings
- Q1 2024 Nykode Therapeutics ASA Earnings Call TranscriptMay 14, 2024kr18.69Earnings
- Q4 2023 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2024kr18.69Earnings
- Q2 2023 Nykode Therapeutics ASA Earnings Call TranscriptAug 23, 2023Earnings
- Nykode Therapeutics ASA at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Nykode Therapeutics ASA Earnings Call TranscriptMay 12, 2023Earnings
- Q4 2022 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2023Earnings
- Nykode Therapeutics ASA Corporate Call TranscriptDec 20, 2022
- Q3 2022 Nykode Therapeutics ASA Earnings Call TranscriptNov 23, 2022Earnings
- Nykode Therapeutics ASA at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Nykode Therapeutics AS at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp TranscriptJul 12, 2021
Q1 2023 Nykode Therapeutics ASA Earnings Call Transcript
Hello, and welcome to the Nykode Therapeutics first quarter 2023 earnings conference call and webcast. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to your host, CEO, Michael Engsig. Michael, please go ahead.
Thank you very much, Kevin, and a very warm welcome to everybody on the call this morning in Norway and Scandinavia. We're going to run this one here for our entire audience, including also the international. So we're going to run it in English this morning here.
So just a quick look at our forward-looking statements. And as usual, we assume that you are familiar with these statements, so we'll quickly move on. Again, as usual, I had to tour you. I'm joined here today by Agnete Fredriksen, our Chief Business Officer and Co-Founder; as well as Harald Gurvin, our Chief Financial Officer. I will take you through both a highlight level of the data that we presented in this quarter here, as well as, of course, a deep dive into
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)